Trinity Capital Inc.
Trinity Capital invests in privately funded, growth-oriented companies to provide stable and consistent returns to investors through exclusive access to the private credit market. The firm leverages in-house underwriting expertise and tailored financial solutions to support long-term value creation for both portfolio companies and investors.
Tritemius Capital
Tritemius Capital backs audacious entrepreneurs building the next Internet, focusing on early-stage startups in the Web3 ecosystem. They aim to support the Web3 ecosystem's definitive leap towards technological maturity and mass adoption. They invest in startups that leverage ownership, interoperability, composability, and scalability within the Web3 space. Their investment focus spans a variety of sectors, encompassing the most rapidly growing areas within the space. Tritemius targets startups in the pre-seed to pre-series A stages, with an average initial investment of €500K. They focus specifically on areas like DeFi, infrastructure, digital identity, video games, social networks, and the metaverse within the Web3 space. Their strategy is geared toward supporting entrepreneurs in navigating the early stages of growth by providing them with the resources and experience needed to build and scale their innovative Web3 ventures.
TruVenturo
TruVenturo operates as a company builder and venture investor, strategically partnering with promising small and medium-sized enterprises (SMEs). They focus on identifying, building, and supporting companies that shape the future of technology. Their approach involves hands-on support from the initial idea to market leadership, focusing on strategy, talent acquisition, capital allocation, and operational excellence. They also make strategic investments in high-potential companies operating in internet, B2B software, neuroscience, and longevity biotech sectors. The firm's vision is to build companies with real impact by developing ventures that redefine industries and create lasting value. They combine deep sector expertise with hands-on execution to empower founders and teams to build market leaders. Their in-house team covers technology, product development, sales, marketing, human resources, finance, and legal aspects, guiding ventures towards sustainable success. TruVenturo emphasizes building alongside founders, offering extensive experience, a global network, and deep sector knowledge in technology, healthcare, and B2B. They prioritize creating real-world impact and long-term value. Founded by Nils Regge, a serial entrepreneur with experience in health and biotech, TruVenturo emphasizes a strong collaborative relationships with industry leaders. Nils has a track record of founding businesses and successful exits including taking HomeToGo public via SPAC IPO.
Truffle Capital
Truffle Capital operates as a "Business Builder," actively creating, financing, and nurturing innovative companies in BioMedTech and Deeptech applied to Finance (Fintech & Insurtech). They prioritize companies with proprietary AI, blockchain, and cybersecurity technologies applied to financial institutions within Fintech. In BioMedTech, they focus on radical innovations and interventional medicine. Truffle systematically acts as a founder in BioMedTech, taking a lead investor role and proactive governance position. Their approach involves fostering strategic partnerships to build a robust ecosystem, accelerating the value and growth of their portfolio companies. They leverage deep leading-edge technology to create an unfair advantage for their portfolio and employ value-based investing to drive capital efficiency and robust growth. The firm aims to identify and develop companies into tomorrow's leaders within their respective fields by consolidating differentiated technologies, industrializing at scale, and creating category leaders attractive to global strategic players and public markets. Truffle Capital appears to take a very active role in company creation within the BioMedTech space, often acting as the founder and taking a lead role in subsequent investment rounds. This hands-on approach allows them to ensure decision-making and guide the company's development. They specifically highlight their success with Abivax as a model for their "Business Builder" approach, aiming to replicate this success with other ventures like Carvolix. ESG is highlighted as being at the center of Truffle Capital's DNA and investment strategy.
Turenne Capital
Turenne Capital positions itself as a leading independent small-cap private equity firm in France. Their strategy focuses on providing expertise, maintaining proximity to their portfolio companies, catering to private clients, and committing to Corporate Social Responsibility (CSR). They aim to support the growth and development of companies, particularly those with regional presence. The firm actively seeks to invest in and support companies in various sectors, contributing to their expansion and value creation. They highlight their employee ownership model as a key aspect of their commitment. Turenne aims for €3 billion AUM by 2027.
Turquoise
Turquoise International is a financial advisor and investor focused on climate technologies. They operate in both financial advisory (M&A, capital raising) and direct investment, primarily through the Low Carbon Innovation Funds (LCIF) and the soon-to-be-launched Redwheel Turquoise ClimateTech Fund. Turquoise aims to reduce Greenhouse Gas Emissions through investments in new technologies and business models and supports later-stage (post-revenue or early-profit) ClimateTech companies. Their strategy encompasses providing advisory services to climate technology businesses, assisting them in securing funding from various sources like venture capital, private equity, infrastructure and sovereign wealth funds, corporate & strategic investors, banks, and high net worth individuals. They also advise companies on mergers, acquisitions, disposals, joint ventures, and secondary share sales, working with early and growth-stage businesses, large corporates, and financial institutions. On the investment side, Turquoise actively manages funds like LCIF, which is currently fully allocated, and is in the process of launching the Redwheel Turquoise ClimateTech Fund to target later-stage ClimateTech companies in the UK. They also offer investment-related services to other investors, including fund establishment and management, investment and advisory committee membership, and individual investment advice. Turquoise’s approach is supported by a team of experienced investment professionals and a network of advisors with expertise across the climate technology landscape. They demonstrate a commitment to supporting companies that contribute to a greener future and offer both financial advisory and investment services to achieve this goal.
Twinco Capital
Twinco Capital is a supply chain finance provider focused on enabling large corporates to offer their suppliers access to affordable funding from purchase order to final invoice payment. They aim to reduce risk and financing costs for both the corporate and its suppliers, thereby building competitive and socially responsible supply chains. Their model involves funding up to 60% of the purchase order value upfront and the remaining portion upon delivery, providing suppliers with crucial liquidity when they need it most. The firm emphasizes a flexible and accessible solution, requiring no letters of credit, collateral, or complex documentation, instead relying on the strength of existing commercial relationships. Twinco's mission is to give producers worldwide access to affordable working capital, fostering competitive global production networks and empowering companies to be engines of inclusive growth.
UG Investments
UG Investments (UGI) is an Estonian investment holding company focused on creating a better and more sustainable living environment through its investments. They provide a solid capital base to sustainable companies with good potential and professional management, with a time horizon suitable for all parties. UGI acts as a responsible and development-oriented owner for its investments. The firm prioritizes reducing environmental impact and promoting responsible business practices across its investments. They collaborate closely with the management and other owners of their portfolio companies.
UI Investissement
UI Investissement supports the growth of unlisted SMEs and mid-sized companies (ETIs) throughout France and at all stages of their development. They engage in Capital Development and Transmission (LBO), Capital Innovation, and Consolidation strategies. They invest in companies to accelerate their growth, industrialize their technology, and consolidate their shareholding. Their approach involves a combination of financial investment and active support, aiming to enhance operational excellence.
UK Innovation & Science Seed Fund
UKI2S invests in early-stage UK science and technology startups emerging from publicly funded research, driving sustainable growth and societal impact.
UK Space Agency
The UK Space Agency's involvement in investments is driven by a strategy to foster the growth of the UK's space economy and establish a leading position in space-enabled manufacturing. This involves supporting companies pioneering in-orbit manufacturing, such as those developing pharmaceuticals in space, by addressing barriers like regulatory uncertainty and supply chain gaps. The agency aims to facilitate the translation of space-based research into practical applications, contributing to advancements in areas like medicine and semiconductor manufacturing. This investment strategy is underpinned by the belief that microgravity environments can offer unique advantages in manufacturing, leading to higher quality and more effective products. The agency's strategy also includes investing in regional infrastructure through initiatives like the Space Clusters Infrastructure Fund (SCIF). This aims to strengthen regional space economies and build sovereign capabilities in strategically important technologies. By funding projects such as the National Microgravity Research Centre, the agency supports the development of terrestrial facilities that complement space-based manufacturing activities. This hybrid approach, combining in-space manufacturing with ground-based processing and scaling, is designed to accelerate the commercialization of space-derived technologies. Furthermore, the UK Space Agency works collaboratively with other government bodies, such as the Medicines and Healthcare products Regulatory Agency (MHRA), the Regulatory Innovation Office (RIO), and the Civil Aviation Authority (CAA), to create a supportive regulatory environment for space-related industries. This includes providing regulatory guidance, establishing regulatory sandboxes, conducting case studies, and engaging with supply chain stakeholders. By offering regulatory clarity and addressing practical challenges, the agency seeks to encourage innovation and attract investment in the UK space sector. Ultimately, the goal is to ensure that the UK remains at the forefront of space technology and can reap the economic and societal benefits of space exploration and utilization.
UK Space Agency - Space Clusters Infrastructure Fund (SCIF)
Based on the provided website content, the UK Space Agency - Space Clusters Infrastructure Fund (SCIF)'s investment thesis revolves around fostering growth and innovation within the UK space sector. The fund aims to achieve this by supporting initiatives that promote space sustainability, accelerate commercial readiness among space entrepreneurs, and facilitate collaboration between UK expertise and international partners. This support extends to various facets of the space industry, including the development and deployment of satellite technologies, the use of space data for environmental and agricultural applications, and the advancement of space communications. The fund's underlying principle is to bolster UK prosperity by ensuring space remains safe, secure, and sustainable for future generations.
UKRI
UK Research and Innovation (UKRI) is the UK's main public funder of research and innovation. Their strategy for 2022-2027 focuses on creating an outstanding research and innovation system in the UK, providing opportunities for everyone to contribute and benefit. This involves advancing knowledge, improving lives, and driving growth nationally and globally. UKRI aims to deliver the government’s ambitions for the UK as a global leader in research and innovation, aligning with plans for growth, R&D roadmap, innovation strategy, R&D people and culture strategy, integrated review, and levelling up white paper. The firm's strategic approach is underpinned by four principles: diversity, connectivity, resilience, and engagement. These principles are fundamental to how UKRI operates and aims to foster a flourishing research and innovation system in the UK. The strategy also outlines six objectives focused on people, places, ideas, innovation, and impacts, supported by UKRI as a world-class organization. UKRI's investment strategy involves funding various research councils, including the Arts and Humanities Research Council (AHRC), Biotechnology and Biological Sciences Research Council (BBSRC), Economic and Social Research Council (ESRC), Engineering and Physical Sciences Research Council (EPSRC), Innovate UK, Medical Research Council (MRC), Natural Environment Research Council (NERC), Research England, and Science and Technology Facilities Council (STFC). UKRI is transitioning to a more strategic, UKRI-wide model for investing in research and innovation, aiming to deliver the greatest possible impact for the public. This involves coordinating funding across different councils and establishing UKRI-wide themes, such as the UKRI Life Sciences Priority Programme under the MRC. The organization is committed to sustaining curiosity-driven research through grant awards and fellowships.
UKTV Ventures
UKTV Ventures operates as a media-for-equity investment fund, backed by the television broadcaster UKTV. Their core strategy involves providing premium advertising inventory on UKTV's diverse portfolio of channels (U&Dave, U&W, U&Gold, and others) in exchange for minority equity stakes in direct-to-consumer (DTC) startups. This approach allows the startups to rapidly scale their brand awareness and customer acquisition through TV advertising, while UKTV Ventures gains equity in potentially high-growth businesses. The fund's objective is to help these companies establish themselves as recognizable brand names within the UK market. The investment proposition is tailored to companies that are ready to leverage television advertising to accelerate their growth. By foregoing traditional cash investment, UKTV Ventures provides a unique value proposition, unlocking access to a broad audience through targeted advertising campaigns. The fund aims to identify companies with a strong product-market fit and the potential to become household names, enabling them to significantly expand their customer base and market presence.
UM6P Ventures
UM6P Ventures is the investment arm of University Mohammed VI Polytechnic (UM6P), established to foster entrepreneurship and accelerate the commercialization of scientific innovations in Morocco and the broader African continent. The firm operates two funds: a Digital Transformation Startup fund and a Deeptech Ventures fund. They invest in pre-seed and seed stages, providing capital and access to resources such as talent sourcing, subject domain expertise, and specialized equipment through the UM6P ecosystem. The firm's vision involves identifying early-stage startups with scalability potential and embedding a venture builder culture to support founding teams. UM6P Ventures aims to bootstrap startups from the pre-seed phase towards a Series A round. They are sector-agnostic but have a focus on deeptech and hardtech startups, particularly those in agriculture, chemicals, greentech, and healthtech. UM6P Ventures looks for startups with a minimum viable product, an identified target customer, high growth potential, a competitive advantage, a skilled and complementary founding team, and a viable business model. They aim to provide early-stage capital to help startups transition into established businesses and ensure continued capital injection and growth through direct investments or regional co-investments. Their model gives startups access to resources, labs, and the UM6P community, along with SMEs to facilitate launch and growth. UM6P Ventures fosters an experience-based learning community by connecting ventures with incubators, accelerators, angel investors, and VCs within a broad ecosystem.
UTokyo Innovation Platform Co., Ltd.
UTokyo Innovation Platform Co., Ltd. (UTokyo IPC) was established in 2016 as the first investment company wholly owned by the University of Tokyo. Its mission is to return the knowledge of research institutions, including the University of Tokyo, to society and create new industries and value. The firm aims to foster an innovation ecosystem originating from academia, supporting startups from their creation to growth. UTokyo IPC focuses on providing not only financial support but also management assistance, community building for entrepreneurs and researchers, collaboration programs with industry, and partnerships with overseas innovation hubs. The firm has evolved from a pure "investment company" to an "ecosystem builder." They aim to create an environment where researchers and entrepreneurs can confidently take on challenges by implementing research knowledge into society and returning it through industry. This involves nurturing talent, circulating funds, and fostering new challenges. UTokyo IPC emphasizes its role as a "Company" committed to responsibility, results, and providing sustainable value to society, acting as a foundation for the long-term growth of university-originated innovation. UTokyo IPC operates three funds: the IPC Fund 1, AOI Fund 1, and ASA Fund, with a combined asset size nearing JPY 60 billion. These funds are used to invest primarily in deep tech startups that aim to solve social issues and have the potential to deliver significant impact. The firm's investment strategy revolves around supporting startups in fields such as life science, healthcare and agritech, space, robotics and hardware, IT and services, and artificial intelligence (AI). The firm also offers incubation and acceleration programs. Startup Building Program is a hands-on support program that works alongside researchers and Entrepreneurs-in-Residence (EIRs) to launch startups, while 1stRound is a Cross-academia Accelerator conducted in collaboration with universities and research institutions. The overarching goal is to link academia with the industrial world, thereby implementing technologies and knowledge into society.
Ukraine Phoenix Tech Fund
Ukraine Phoenix Tech Fund invests in early-stage Ukrainian tech companies with high-growth potential, providing funding, mentorship, and access to global markets.
Unifund
Based on the provided context, Unifund is a venture capital firm that appears to be based in Greece and focused on investing in early-stage startups. An article on startupper.gr mentions an €850,000 investment by Unifund in Tekmon and CollegeLink, indicating a focus on supporting Greek startups. While the specific investment thesis isn't explicitly detailed, the focus on Greek startups and investments in companies like Tekmon and CollegeLink suggest an interest in technology-driven businesses with growth potential. Further research would be needed to define a comprehensive investment thesis and strategy description for the firm.
Unilever Ventures
Unilever Ventures is the venture and growth capital arm of Unilever, focusing on supporting forward-thinking founders who are building brands for the modern consumer. They aim to empower entrepreneurs with big ideas, helping them create strong brands or technology solutions that stand out and move the world forward. With over twenty years of experience, they bring expertise and leadership in the consumer goods industry, offering a unique blend of the global reach of Unilever and the agility of a skilled venture capital team. They seek to back brands of tomorrow and the technologies that enable them to succeed in large markets. Their investments span across beauty and wellness brands, commerce and enabling technologies, and B2B/enterprise technologies. They are particularly interested in emerging brands operating across both digital and physical worlds that are relatable and authentic, as well as services and technologies that enhance the consumer experience and transmute commerce. Their approach is tailored to the specific needs of consumer startups, providing access to Unilever's global network, operational expertise, and deep understanding of consumer preferences. Unilever Ventures provides a platform to help companies scale efficiently and reach a broad consumer base. By combining the resources of a corporate giant with the nimbleness of a venture capital firm, they aim to provide the "best of both worlds" to their portfolio companies. Ultimately, Unilever Ventures invests in companies that align with Unilever's broader mission of creating brands that consumers love, supporting innovation and sustainability, and driving positive change in the world. The firm offers value beyond capital, with expertise in building brands and scaling businesses.
Uniqa Ventures
Uniqa Ventures is not directly mentioned in the crawled pages. The provided content focuses on UNIQA Österreich Versicherungen AG, an Austrian insurance company. The company offers a range of insurance products, including private health insurance, and emphasizes sustainability in its operations. They aim to achieve climate neutrality in Austria by 2040 and in CEE countries by 2050. They operate with a focus on ESG criteria for investments and product development. The company also provides customer service and information through its website and other channels.
University of Tokyo Innovation Platform (UTokyoIPC)
UTokyo Innovation Platform (UTokyoIPC) is the first investment firm wholly owned by the University of Tokyo, established in 2016. It aims to foster an innovation ecosystem originating from academia by supporting startups from creation to growth. The firm seeks to translate research and knowledge from the University of Tokyo and other research institutions into societal impact, creating new industries and value. They believe that innovation requires collaboration between researchers, entrepreneurs, investors, corporations, and government, leveraging the strengths of each to implement research outcomes and generate sustainable value. UTokyoIPC provides financial support and management assistance to university-based startups, fosters communities for entrepreneurs and researchers, develops collaborative programs with industry, and partners with international innovation hubs. This comprehensive approach aims to increase the number and growth rate of university-launched startups, enabling them to achieve both domestic and international recognition. They are evolving from a traditional investment company to an ecosystem builder, offering not just funding but also industry-academia collaboration and talent development programs to nurture the next generation of innovators. The firm's mission is to create an environment where researchers and entrepreneurs can confidently pursue their ventures, translating academic knowledge into societal applications and industrial advancements. This process encourages talent development, capital circulation, and the emergence of new challenges. UTokyoIPC aims to be a foundational company that supports the long-term growth of university-driven innovation, striving to create a societal base that cultivates the seeds of challenge into future achievements. Their focus lies in addressing societal challenges through deep tech ventures in areas like climate change, natural disasters, aging populations, food shortages, and energy crises.
Unknown Group
Unknown Group focuses on supporting entrepreneurs who are building solutions for a better world. They are constructing what they claim to be the largest impact campus in Europe, centered around a leading university for entrepreneurs. Their strategy includes identifying exceptional founders through initiatives like "Get in the Ring" and supporting their growth through campus facilities and university programs. They emphasize providing a physical space for founders to work, connect, and test solutions, alongside educational opportunities to further develop their businesses. The core of their investment and support strategy involves creating an ecosystem designed to foster the development of impactful and sustainable businesses.
Utrecht Health Seed Fund
Utrecht Holdings Seed Fund (UHSF) invests in science-based startups originating from or closely linked to Utrecht University (UU) and University Medical Centre Utrecht (UMCU). The fund builds upon the success of the UtrechtHealthSeed Fund (UHSF I). Their primary aim is to translate scientific research into broader societal impact by providing early-stage funding to innovative companies. They are committed to supporting ventures that address pressing challenges in healthcare and sustainability, with a focus on creating impactful solutions leveraging cutting-edge research and technologies from UU and UMCU. The fund's investment strategy reflects the research strengths of its investors, primarily focusing on Life Sciences/MedTech, Digital Innovation, and Sustainability. UHSF seeks to bridge the gap between academic research and commercial application by providing crucial seed funding to spin-offs and startups that have demonstrated a clear potential for scalability and positive impact. They are actively looking for opportunities where the innovations are deeply rooted in scientific breakthroughs. The fund invests in companies located in the Netherlands, particularly those connected to the Utrecht ecosystem. They are especially interested in innovations coming from and linked to Utrecht University and University Medical Center Utrecht. The firm intends to foster an environment where early-stage ventures can thrive by providing not only financial backing but also leveraging the vast network, knowledge base, and infrastructure of Utrecht Holdings, Utrecht University and UMCU. The goal is to advance translational science, fostering the growth of innovative businesses and contributing to economic development in the region. UHSF is managed by Utrecht Holdings, the Knowledge Transfer Office of the UU and UMCU, further cementing the alignment with the strategic research priorities and ensuring a close relationship with the source of innovative technologies. The fund seeks to create an ecosystem where academic research can be translated into tangible benefits for society and is actively involved in nurturing and mentoring companies in the early stages. They operate with a collaborative mindset, partnering with other investors and stakeholders to maximize the chances of success for their portfolio companies.
V-Bio Ventures
V-Bio Ventures is a life science venture capital fund that focuses on co-creating startups and investing in early- to mid-stage companies with high growth potential. Their core mission is to transform scientific innovation into products that positively impact people’s lives. The firm's investment strategy centers on identifying and supporting companies with differentiated technology addressing unmet needs. They actively seek innovative and transformational technologies with high societal and/or environmental impact potential within the therapeutics sector, encompassing both drug discovery and drug development. V-Bio Ventures leverages its extensive network and sector expertise to provide more than just capital. They aim to be an integral part of the ventures they back, contributing actively to their development. A preferred relationship with VIB, a prominent life science research institute in Belgium, serves as a key source for co-created companies built on VIB-derived innovations. However, they also source deals from research institutes, entrepreneurial initiatives, and spin-outs from established companies across Europe. The firm has a broad investor base that includes financial institutions, governmental bodies, private family offices, and academic institutions. A portion of their funds are supported by InnovFin Equity, backed by the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI), which aims to facilitate financing and implementation of productive investments in the European Union and increase access to financing. Overall, V-Bio Ventures focuses on building a healthier future by investing in companies that leverage great science and empowering talented entrepreneurs. The firm supports its portfolio companies with capital and expertise, facilitating the transformation of scientific innovations into impactful solutions.